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Abstract. 
 
Axin was identiﬁed as a regulator of embry-
onic axis induction in vertebrates that inhibits the Wnt 
signal transduction pathway. Epistasis experiments in 
frog embryos indicated that Axin functioned down-
 
stream of glycogen synthase kinase 3
 
b 
 
(GSK3
 
b
 
) and 
upstream of 
 
b
 
-catenin, and subsequent studies showed 
that Axin is part of a complex including these two pro-
teins and adenomatous polyposis coli (APC). Here, we 
examine the role of different Axin domains in the ef-
fects on axis formation and 
 
b
 
-catenin levels. We ﬁnd 
that the regulators of G-protein signaling domain (ma-
jor APC-binding site) and GSK3
 
b
 
-binding site are re-
quired, whereas the COOH-terminal sequences, includ-
ing a protein phosphatase 2A binding site and the DIX 
domain, are not essential. Some forms of Axin lacking 
the 
 
b
 
-catenin binding site can still interact indirectly 
with 
 
b
 
-catenin and regulate 
 
b
 
-catenin levels and axis 
formation. Thus in normal embryonic cells, interaction 
with APC and GSK3
 
b
 
 is critical for the ability of Axin 
to regulate signaling via 
 
b
 
-catenin. Myc-tagged Axin is 
localized in a characteristic pattern of intracellular 
 
spots as well as at the plasma membrane. NH
 
2
 
-terminal 
sequences were required for targeting to either of these 
sites, whereas COOH-terminal sequences increased lo-
calization at the spots. Coexpression of hemagglutinin-
tagged Dishevelled (Dsh) revealed strong colocaliza-
tion with Axin, suggesting that Dsh can interact with 
the Axin/APC/GSK3/
 
b
 
-catenin complex, and may thus 
modulate its activity.
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A
 
XIN
 
 is the product of the murine genetic locus origi-
 
nally called 
 
Fused
 
, in which mutations cause a
variety of developmental defects (Gluecksohn-
Schoenheimer, 1949; Theiler and Gluecksohn-Waelsch,
1956; Jacobs-Cohen et al., 1984). The 
 
Axin
 
 gene was
cloned with the aid of an insertional mutation and found
to potentially encode a protein of up to 992 amino acids
(aa)
 
1
 
 (Perry et al., 1995; Zeng et al., 1997). Axin contains
two conserved domains, a regulators of G-protein signal-
ing domain (RGS; Dohlman and Thorner, 1997) near its
NH
 
2
 
 terminus and a COOH-terminal DIX domain (also
found in Dishevelled [Dsh]; Cadigan and Nusse, 1997) that
suggested a role in signal transduction. More specific in-
sight into the function of Axin came from studies of its ef-
fects on vertebrate embryogenesis. The occurrence of ax-
ial duplications in loss-of-function 
 
Axin
 
 mutants in the
mouse suggested that the gene might play a negative regu-
latory role in an early step in axis formation. This hypothe-
sis was tested and confirmed by the ability of overex-
pressed Axin to block dorsal axis formation in 
 
Xenopus
 
embryos. Further studies showed that the effect of Axin is
due to its specific ability to inhibit signal transduction
through components of the Wnt pathway and suggested
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that Axin functioned downstream of glycogen synthase ki-
nase 3
 
b
 
 (GSK3
 
b
 
) and upstream of 
 
b
 
-catenin (Zeng et al.,
1997).
 
b
 
-Catenin is thought to serve as a key mediator of Wnt
signal transduction that is regulated through the following
mechanism (for review see Gumbiner, 1995; Peifer, 1995;
Miller and Moon, 1996; Cadigan and Nusse, 1997). In the
absence of a Wnt signal, 
 
b
 
-catenin is confined to the
plasma membrane, where it stably is associated with cad-
herin adhesion molecules. Cytosolic 
 
b
 
-catenin levels are
very low because free 
 
b
 
-catenin is a target for GSK3
 
b
 
-
dependent phosphorylation and is degraded rapidly via
the ubiquitin pathway. In the presence of a Wnt signal,
GSK3
 
b
 
 phosphorylation of 
 
b
 
-catenin is inhibited, free
 
b
 
-catenin is stabilized, accumulates in the cytoplasm, and
is imported into the nucleus. 
 
b
 
-Catenin can interact with
HMG-box transcription factors of the TCF/Lef-1 family,
leading to activation of specific target genes.
Despite the apparent simplicity of this signaling cascade,
the mechanisms involved in the regulation of 
 
b
 
-catenin are
still rather obscure. For instance, it is still not known
whether upstream components (Wnt, Frizzled, Dsh) affect
GSK3
 
b
 
 activity or the accessibility of 
 
b
 
-catenin to GSK3
 
b
 
.
The tumor suppressor gene product adenomatous polypo-
sis coli (APC), which also binds directly to 
 
b
 
-catenin, ap-
pears to be required to maintain low levels of 
 
b
 
-catenin in
mammalian cell lines (Munemitsu et al., 1995). However,
experiments in embryonic systems are inconsistent with
APC being only a negative regulator of 
 
b
 
-catenin and sug-
gest that it might, on the contrary, be an activator of the
pathway (Rocheleau et al., 1997; Vleminckx et al., 1997).
Finally, there is still no definitive evidence that regulation
of the 
 
b
 
-catenin level is the only important parameter in
 
b
 
-catenin signaling, or whether phosphorylation could af-
fect directly its signaling activity. The apparent involvement
of Axin in Wnt signal transduction, at a level close to GSK3
 
b
 
and 
 
b
 
-catenin, indicated that Axin might be at the heart of
the process of 
 
b
 
-catenin phosphorylation/degradation.
To investigate the mechanism by which Axin partici-
pates in the regulation of Wnt signal transduction, we un-
dertook a study of the interaction of Axin with various
components of the Wnt pathway. We also carried out a
functional dissection of the role of different regions of
Axin in its ability to ventralize frog embryos (an in vivo as-
say for inhibition of 
 
b
 
-catenin signaling) or to influence
the levels of 
 
b
 
-catenin in the frog embryo. During the
course of this work, several publications have described
the direct interaction of Axin with APC, GSK3
 
b
 
, and
 
b
 
-catenin (Hart et al., 1998; Ikeda et al., 1998; Itoh et al.,
1998; Kishida et al., 1998; Sakanaka et al., 1998). These re-
ports suggested that the primary function of Axin was to
bind GSK3
 
b
 
 and 
 
b
 
-catenin simultaneously, thus promot-
ing the phosphorylation of 
 
b
 
-catenin and its subsequent
degradation. Similar results have been reported for an
Axin homologue called Axil or Conductin (Behrens et al.,
1998; Yamamoto et al., 1998). Both Axin and Axil/Con-
ductin were found to bind to APC through their RGS do-
mains (Behrens et al., 1998; Hart et al., 1998) and to
GSK3
 
b
 
 and 
 
b
 
-catenin through two distinct central do-
mains (Behrens et al., 1998; Ikeda et al., 1998), thus medi-
ating the formation of a multiprotein complex. However,
the RGS (APC-binding) domain was not required for
 
Axin to stimulate the phosphorylation of 
 
b
 
-catenin in vitro
or its turnover in SW480 colon cancer cells (Behrens et al.,
1998; Hart et al., 1998; Ikeda et al., 1998), raising questions
about the role of APC in this complex. In addition to these
proteins, Axin has been found to have a binding site for
the serine/threonine protein phosphatase 2A (PP2A),
which might modulate phosphorylation of proteins in the
complex, and another region that mediates multimeriza-
tion with other Axin molecules. The latter region includes
the DIX domain, which is highly conserved between Axin
and Dsh, suggesting that Axin and Dsh might also interact
through this domain (Hsu et al., 1999).
In the studies reported here, we have examined the re-
gions of Axin required for its role in the regulation of axis
formation and 
 
b
 
-catenin levels in the frog embryo. We
have found that in this system both the RGS domain and
GSK3
 
b
 
 binding sites, but not necessarily the 
 
b
 
-catenin
site, are essential for activity. We have shown that epitope-
tagged Axin expressed in frog embryos is localized to the
plasma membrane and to a characteristic type of intracel-
lular spots and have delimited the sequences in Axin that
mediate this pattern of localization. Finally, we have found
that epitope-tagged forms of Axin and Dsh show strongly
overlapping patterns of localization when coexpressed,
suggesting that Dsh can also form part of the Axin com-
plex.
 
Materials and Methods
 
Plasmid Construction
 
To express Myc-tagged forms of Axin, the coding region of mouse Axin
(form 1) sequence was inserted downstream of the SP6 promoter in the
vector pCS2-MT (Rupp et al., 1994). DNA inserts amplified by PCR with
 
Pfu
 
 DNA polymerase (Stratagene) were used for the construction of plas-
mids containing small fragments, such as Ax455-552, Ax497-672, etc. Full-
length (FL) 
 
Xenopus
 
 APC cDNA (Vleminckx et al., 1997) was inserted
downstream of the CMV/SP6 promoter in the pCS2 vector, with a 5
 
9
 
5
 
3 
 
VSV-G (vesicular stomatitis virus glycoprotein) tag (YTDIEMNR-
LGK). Human Myc epitope-tagged APC constructs used for direct bind-
ing assays were described previously (Vleminckx et al., 1997). pET32 vec-
tor (Novagen, Inc.) was used to produce the His
 
?
 
S tagged Axin fusion
proteins. The reading frame of all constructs was confirmed by sequencing
and detection of expected sized bands in Western blot or Coomassie bril-
liant blue R250 stained SDS–polyacrylamide gels. Plasmids for transfec-
tion and in vitro transcription/translation were isolated using the midi-
prep kit (QIAGEN Inc.). Other constructs used included: Myc-tagged
 
Xenopus
 
 
 
b
 
-catenin (Fagotto et al., 1996), hemagglutinin (HA)-tagged
 
Xenopus
 
 
 
b
 
-catenin (Funayama et al., 1995), HA-tagged 
 
Xenopus
 
 Dsh
(gift of Dr. U. Rothbächer, University of Marseille, France), HA-tagged
dominant negative human GSK3
 
b
 
 (gift of Dr. X. He, Harvard Medical
School, Boston, MA).
 
Antibodies
 
Antibodies were purchased from the indicated sources: anti–
 
b
 
-catenin
mouse mAb, clone 14, and anti-GSK3
 
b
 
 mAb, clone 7, Transduction Labo-
ratories; anti–VSV-G mAb P5D4, Boehringer Mannheim; anti-Myc
9E10.2 mAb, Calbiochem-Novabiochem; anti–HA-tag rabbit polyclonal
antibodies (pAb), Santa Cruz Biotechnology; and anti–
 
b
 
-galactosidase
rabbit pAb, Cappel Laboratories and Organon Teknika Corp. Anti-Myc
rabbit pAb was raised against the c–Myc-epitope tag (EQKLISEEDL)
and affinity-purified. Anti-HA mAb 12CA5 was a gift from Dr. P. Mc-
Crea (M.D. Anderson Cancer Center, Houston, TX).
 
Tissue Culture and Transient Transfection
 
293 cells, obtained from the American Type Culture Collection, were cul-
tured in DME/F12 medium (Mediatech) supplemented with 10% FBS 
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(HyClone Laboratories Inc.) in humidified 6% CO
 
2
 
. Cells were trans-
fected using a calcium phosphate mammalian cell transfection kit (5 Prime
 
®
 
3 Prime, Inc.). The next day cells were collected and lysed and analyzed
for transient expression of transfected DNAs.
 
Immunoprecipitation (IP) and Western Blot
 
For IP and Western blot analysis, 293 cells were washed with PBS, pH 7.2,
and lysed in lysis buffer (150 mM NaCl, 5 mM EDTA, 50 mM NaF, 50 mM
KH
 
2
 
PO
 
4
 
, 10 mM sodium molybdate, 20 mM Tris-HCl, pH 7.4, 5 
 
m
 
g/ml
aprotinin, 5 
 
m
 
g/ml leupeptin, 0.6 mM DTT, 2 mM sodium orthovanadate,
0.2 mM PMSF, 1% Triton X-100). After 20 min at 4
 
8
 
C with constant rota-
tion, the lysate was centrifuged at 14,000 
 
g
 
 for 15 min and the supernatant
was saved. Protein concentration was measured by the Lowry method
(Lowry et al., 1951). For coimmunoprecipitation (coIP) of Axin/APC/
 
b
 
-catenin/GSK3
 
b
 
 complex, 150–300 
 
m
 
g (total protein) of cell lysate was
incubated with 1–2 
 
m
 
g of an appropriate antibody in lysis buffer for 2 h
at 4
 
8
 
C with constant rotation. 30 
 
m
 
l of protein A/G plus–agarose (Santa
Cruz Biotechnology) was added and the incubation continued for an addi-
tional 1.5 h. Immunoprecipitates were pelleted and washed three times
with lysis buffer. Immunoprecipitates were analyzed by SDS-PAGE (5%
acrylamide for APC detection, 10% for detection of other proteins) and
Western blot, using HRP-conjugated donkey anti–rabbit and sheep anti–
mouse secondary antibodies (Amersham Life Science) and the chemilu-
minescence system (RENAISSANCE™; NEN Life Science Products).
Approximately 10–20 
 
m
 
g of protein was used to detect expression of the
various constructs.
 
Direct Binding Assay
 
Myc-APC constructs were produced with TNT coupled wheat germ ex-
tract system (Promega). These [
 
35
 
S]Met-labeled proteins were incubated
with 2 
 
m
 
g of bacterially expressed S-tagged Axin fusion proteins in 500 
 
m
 
l
of buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2 mM EDTA, 5 mM
DTT, 5 
 
m
 
g/ml aprotinin, 5 
 
m
 
g/ml leupeptin, 0.1 mM PMSF, 0.5% NP-40 at
37
 
8
 
C for 10 min and at 4
 
8
 
C for 10 min. The protein complexes were precip-
itated with 30 
 
m
 
l S-protein agarose (Novagen), washed three times with
the same incubation buffer, and analyzed by SDS-PAGE (7.5% gel) and
autoradiography.
 
Mobility Shift Assay
 
Lysates from cells transiently expressing VSV-G–tagged APC (VSV–
APC) and Axin constructs were used for IP with anti–VSV-G P5D4 mAb.
Immunoprecipitates were incubated with 1,000 U of 
 
l
 
-protein phos-
phatase (New England Biolabs Inc.) in 50 
 
m
 
l reaction buffer (50 mM Tris-
HCl, pH 7.8, 5 mM DTT, 2 mM MnCl
 
2
 
, and 100 
 
m
 
g/ml BSA) at 30
 
8
 
C for 30
min. 
 
l
 
-Protein phosphatase-treated samples were separated by SDS-
PAGE (5% gels) and VSV–APC was detected by immunoblot using the
P5D4 mAb.
 
Embryo Injection and Scoring
 
mRNA was synthesized using SP6 polymerase (Promega) and dissolved in
diethyl pyrocarbonate–treated water. For ventralization assays, 15 nl
mRNA was injected in the subequatorial region of the two dorsal blas-
tomeres of a four cell stage embryo. For axis duplication assays, 15 nl
mRNA was injected in one ventral blastomere. Ventralization was scored
at tailbud/tadpole stages according to the dorsoanterior index (Kao and
Elinson, 1988). Axis duplication was scored at neurula/tailbud stage, in
four categories (Fagotto et al., 1997): (1) complete secondary axis (includ-
ing cement gland), (2) partial axis (no cement gland), (3) vestigial axis
(small remnants, blebs), and (4) normal. Only complete and partial axes
were considered as bonafide secondary axes.
 
Expression Levels in Embryos
 
Expression levels of Myc-tagged Axin constructs were determined from
NP-40 extracts of late blastula–early gastrula embryos (stage 9–10 1/2) by
SDS-PAGE and immunoblot, using the anti–Myc-tag 9E10.2 mAb. NP-40
buffer had the following: 1% NP-40, 100 mM NaCl, 10 mM Hepes, pH 7.4,
1 mM EDTA, with a cocktail of protease inhibitors (1 mM PMSF, 1 
 
m
 
g/ml
pepstatin A, 2 
 
m
 
g/ml leupeptin, 4 
 
m
 
g/ml aprotinin, 10 
 
m
 
g/ml antipain, 50
mg/ml benzamidine, 10 mg/ml soybean trypsin inhibitor, 100 mg/ml iodo-
acetamide).
Cell Fractionation
Early cleaving embryos were coinjected with 1 ng Myc-tagged Axin (Myc–
Axin) and 3 ng b-galactosidase mRNA. At stage 9–10, 10 embryos were
homogenized in 500 ml 250 mM sucrose, 110 mM potassium acetate, 10
mM Hepes, pH 7.4, 2 mM magnesium acetate, 2 mM DTT, 1 mM EDTA
supplemented with protease inhibitors. The homogenate was centrifuged
for 5 min at 1,500 g, and the low speed pellet was extracted in NP-40
buffer. The low speed supernatant was fractionated further by centrifuga-
tion for 30 min at 100,000 g in a tabletop ultracentrifuge (TL-100; Beck-
man Instruments Inc.) into a high speed pellet and supernatant. The frac-
tions were analyzed for Myc–Axin and b-galactosidase by SDS-PAGE
and immunoblot.
Con A Precipitation
FL Axin or various mutant constructs mRNA were injected into 4–8-cell
stage embryos. At stage 9–10, pools of six embryos were extracted in 500 ml
NP-40 buffer and each extract was incubated with 50 ml of Con A–agarose
beads (75% slurry; Sigma Chemical Co.) for 1–2 h at 48C. The beads were
spun down, the supernatant was collected (unbound fraction), the beads
washed three times with 1 ml NP-40 buffer, and extracted by boiling in
SDS-PAGE sample buffer (bound fraction). Levels of Myc–Axin con-
structs in bound and unbound fractions were analyzed by SDS-PAGE and
immunoblot using the anti-Myc 9E10 mAb.
b-Catenin Stability
HA-tagged b-catenin mRNA (75 pg) was coinjected with b-galactosidase
mRNA (control) or various Axin mutant mRNAs. Amounts of mRNA in-
jected were the following: b-galactosidase, 1 ng; FL Axin (Ax12-956), 1 ng;
Ax12-531, 0.5 ng; Ax194-530, 0.5 ng; Ax194-672, 0.25 ng; AxD251-351, 1 ng;
Ax331-956, 0.5 ng; and Ax531-956, 0.5 ng. Total amounts of injected
mRNA were adjusted to 1.075 ng by addition of b-galactosidase mRNA.
In some experiments (see Fig. 5 C), higher levels of b-catenin were tested
using 0.75–1.5 ng mRNA. Embryos were extracted in NP-40 buffer at
stage 9–10 and either directly analyzed by SDS-PAGE and immunoblot,
or cleared from cadherin-bound b-catenin as follows: six embryos were
extracted in 200 ml NP-40 buffer. 50 ml of Con A–agarose beads (75%
slurry) were added, and the samples were incubated with constant mixing
for 1–2 h. The beads were spun down and discarded and the superna-
tant was analyzed for b-catenin levels using an anti–HA-tag rabbit anti-
body (Santa Cruz Biotech.), as well as for Axin mutant levels using the
9E10.2 mAb.
Immunofluorescence (IF)
Stage 9–11 embryos were fixed in 4% paraformaldehyde, 100 mM Hepes,
pH 7.4, 100 mM NaCl for 1 h at room temperature, then in Dent’s fixative
(20% DMSO, 80% methanol) overnight at -208C. They were rinsed in 100
mM Tris-HCl, 100 mM NaCl, and embedded in 15%, then 25% fish gela-
tin, and 10-mm cryosections were prepared as described (Fagotto and
Gumbiner, 1994; Fagotto, 1999). Sections were labeled with 9E10.2 mAb
and anti–mouse Oregon green488 or Alexa488 secondary antibodies (Mo-
lecular Probes Inc.), the yolk counterstained with Eriochrome back, and
nuclei with 49,6-diamidino-2-phenylindole (DAPI) as described (Fagotto,
1999). For double staining, sections from embryos coinjected with Myc–
Axin and HA-tagged Dsh (HA–Dsh) mRNAs (1 ng each) were stained
simultaneously with anti-Myc rabbit pAb and anti-HA mAb 12CA5,
followed by Alexa488 goat anti–rabbit and Cy3 donkey anti–mouse
(Dianova) secondary antibodies.
For localization of Myc–Axin in cultured cells, HeLa cells cultured in
DMEM were transfected with pCS2-Myc–Axin using LipofectAmine
(GIBCO BRL). 36-48 h after transfection, cells were fixed in 4%
paraformaldehyde/PBS, permeabilized with 0.05% Triton X-100, and la-
beled with anti-Myc 9E10.2 mAb and Cy3 goat anti–mouse (Dianova)
secondary antibodies. Nuclei were counterstained with DAPI. Samples
were observed with an Axioplan epifluorescence microscope (Zeiss) using
standard fluorescein and Cy3 filters, and digital images were collected us-
ing a camera (768x576 3CCD color video; Sony).
Electron Microscopy and Immunogold Labeling
Preembedding labeling was performed as described (Kurth, 1997; Fagotto,
1999). In brief, embryos expressing FL Myc–Axin or Myc-AxD531-810
were fixed at stage 10 with 4% paraformaldehyde, 0.02% glutaraldehyde,The Journal of Cell Biology, Volume 145, 1999 744
and 100 mM Hepes-NaOH. Labeling was performed by incubating 100-mm
vibrotome sections with the 9E10.2 mAb and a Nanogold-coupled anti–
mouse secondary antibody, followed by silver enhancement. The reaction
produced electron dense aggregates with a diameter of z20–60 nm (see
Fig. 8, C–E). The sections were embedded in Spurr resin and ultrathin sec-
tions were prepared.
Postembedding labeling was performed on small blebs obtained from
the wounds of injected embryos. These blebs contained a large number of
Axin-expressing cells, and their ultrastructure was better preserved than
in whole embryos (Kurth, 1997). Paraformaldehyde/glutaraldehyde-fixed
samples were processed for Lowycryl embedding, ultrathin sectioning,
and immunogold labeling (9E10.2 mAb and 15 nm gold-coupled protein
G) according to standard procedures.
Results
Binding of Full-length and Mutant Forms of Axin to 
APC, GSK3b, and b-Catenin
When epitope-tagged full-length Axin (amino acids 12–
956) was expressed in 293 cells, endogenous GSK3b and
b-catenin, as well as VSV-epitope tagged APC (VSV–
APC), could be coimmunoprecipitated (coIP) with Axin.
A variety of mutant forms of Axin were used next for coIP
and direct binding assays to further delimit the regions of
Axin required for these interactions (Figs. 1 and 2 and
data not shown) and to compare binding abilities with ac-
tivity in functional assays (see below). The results are sum-
marized in Fig. 3, which includes a schematic diagram of
Axin, indicating the locations of the major binding sites for
these proteins as well as PP2A binding and Axin self-bind-
ing (Hsu et al., 1999).
The region of rAxin corresponding to aa 561–630 of
mAxin has been shown to contain a b-catenin binding site
(Ikeda et al., 1998) and our results confirmed that all Axin
mutants containing this region could coIP with endoge-
nous b-catenin. However, several mutants that lacked this
region but included the RGS domain (APC binding site)
were also able to coIP with b-catenin (Ax12-531, Ax194-
531, and AxD531-810) (Fig. 1 A and data not shown). This
may be due to indirect interaction with b-catenin via APC,
because deletion of the RGS domain from this mutant
Axin (Ax12-531D251-351), which eliminated APC binding
(see below), also eliminated coIP with b-catenin (Fig. 1
A). The 85-aa region of rAxin corresponding to mAxin
477–561 was reported to bind to GSK3b (Ikeda et al.,
1998). We found that Ax497-600, Ax403-552, and Ax455-
552 all showed strong coIP with GSK3b (Fig. 1 B), indicat-
ing that the binding site is located in the 55-aa segment be-
tween aa 497 and 552. Mutants that terminate at aa 531
either coIP very weakly (Ax12-531 and Ax194-531) or fail
to coIP with GSK3b (Ax12-531D251-351), suggesting that
truncation at this site partially disrupts the GSK3b binding
site (Figs. 1 B and 3).
The RGS domain of Axin has been identified as a site
for direct interaction with the 20-aa repeat region of APC
(Hart et al., 1998; Kishida et al., 1998). We confirmed that
only Axin fragments including the RGS domain could
bind to the 20-aa repeat region of APC (APC2 or APC25)
(Fig. 2, A–C). However, we also found that a second re-
gion of Axin, between aa 96–253, could bind directly to the
NH2-terminal region of APC (APC21), which contains the
Armadillo repeats and 15 aa repeats (Fig. 2 C). coIPs of
the Axin mutants with VSV–APC generally were depen-
dent on the RGS domain: all mutants containing this do-
main were able to coIP with VSV–APC, whereas all but
one of those lacking it failed to coIP with VSV–APC (Figs.
2 D and 3). However, Ax331-956 also was able to coIP
with APC, probably via b-catenin (Fig. 2 D). The second
APC binding region (aa 96–253) was not sufficient for
coIP with VSV–APC (Fig. 2 D, AxD251-351). Whether
Ax12-355 or Ax12-167 could coIP with VSV–APC could
not be determined because expression of these mutant
Axins resulted in a strong reduction in the level of VSV–
APC (Fig. 2 E and data not shown).
Axin Overexpression Induces Phosphorylation of APC 
In Vivo
When FL Axin and VSV–APC were cotransfected into
293 cells, the electrophoretic mobility of VSV–APC was
reduced compared with control cells cotransfected with
VSV–APC plus pCS2 vector. Ax12-810 and Ax12-531
caused a similar mobility shift, whereas AxD231-351,
Ax12-355, and Ax497-672, which lack either the GSK3b or
APC binding site, did not (Fig. 2 E). It has been shown
that phosphorylation of APC by GSK3b (Rubinfeld et al.,
1996) can be stimulated by Axin in vitro (Hart et al., 1998).
Figure 1. In vivo interaction of Myc-tagged Axin and mutant Axin constructs with endogenous b-catenin (A) or GSK3b (B). Myc-
tagged Axin constructs were expressed in 293 cells. Cell lysates were immunoprecipitated with anti-Myc mAb and immunoprecipitates
were analyzed for endogenous b-catenin or GSK3b by Western blot (upper panels in A and B). Expression of the transfected Myc–
Axin constructs (asterisks) is shown in the lower panels.Fagotto et al. Structure-Function Analysis of Axin 745
To test whether this Axin-induced mobility shift was due
to phosphorylation, the immunoprecipitated proteins were
treated with l-protein phosphatase before immunoblot
analysis with anti-VSV. This treatment eliminated the mo-
bility shift, indicating that it was due to phosphorylation
(Fig. 2 F). This suggests that binding of APC and GSK3b
to Axin promotes the phosphorylation of APC in vivo,
presumably by GSK3b (Rubinfeld et al., 1996).
Axin Sequences Necessary for Ventralization of 
Xenopus Embryos
We previously have shown that the ability of Axin to in-
hibit dorsal axis formation, when expressed in early Xeno-
pus embryos, is due to its inhibitory effect on the Wnt sig-
naling pathway (Zeng et al., 1997). Therefore, we used this
assay to delimit the sequences in Axin required for its neg-
ative effects on signaling through the Wnt pathway. 22 mu-
tant forms of Axin were expressed by mRNA injection on
the dorsal side of 4-cell stage embryos that were cultured
to the tadpole stage and examined for the extent of dorsal
axis formation (fraction of embryos ventralized and dorso-
anterior index). The amount of injected mRNAs was sys-
tematically titrated to obtain comparable levels of expres-
sion for the various mutants. The results are summarized
in Fig. 3, the data are listed in Table I and examples are
shown in Fig. 4.
As we previously reported (Zeng et al., 1997), an in-
ternal deletion of the RGS domain (AxD251-351) elimi-
nated the ability to ventralize and instead caused dorsal-
ization. Deletion of the GSK3b and b-catenin binding sites
(AxD352-631) also abolished ventralizing activity. A small
fragment containing the GSK3b and b-catenin binding
sites (Ax497-672) was insufficient to ventralize the em-
bryo, although similar Axin fragments were able to pro-
mote phosphorylation of b-catenin in vitro (Ikeda et al.,
1998). A fragment containing only the RGS domain
(Ax194-353) was also ineffective.
Successive truncation from the NH2 terminus of Axin
confirmed the importance of the RGS domain for ventral-
ization. Whereas removal of the first 193 aa had no signifi-
cant effect, further truncation to aa 331 eliminated ventral-
izing activity and resulted in dorsalizing activity, similar to
the internal RGS deletion (Fig. 4, D and F). Truncation at
aa 531, removing both the RGS domain and GSK3b bind-
ing region, eliminated all activity (Fig. 4 C) as did trunca-
tion to aa 810 (Ax810-956).
Mutant Axins with NH2-termini at aa 194 were sub-
jected to COOH-terminal truncation to examine the im-
portance of the DIX, PP2A binding, b-catenin binding,
and GSK3b binding domains. Removal of the DIX do-
main (Ax194-810) had little if any effect, whereas removal
of the DIX and PP2A binding domains (Ax194-672)
caused an increase in ventralizing activity (Fig. 4 B). This
observation is consistent with the hypothesis that the bind-
ing of PP2A to the Axin complex may negatively regulate
the phosphorylation of b-catenin by GSK3b (Hsu et al.,
1999). Further truncation to aa 531, removing the b-cate-
nin binding site, abolished ventralizing activity, and in-
stead resulted in some dorsalizing activity (i.e., shorter
axis, larger head, and circular or double cement gland; Fig.
4 E). When injected at high concentrations, the other Axin
mutants lacking the NH2-terminal and the COOH-termi-
nal regions (Ax194-672 and Ax194-810) also showed dor-
salizing activity, as discussed below.
When the NH2 terminus of Axin was left intact, trunca-
Figure 2. Axin binds to APC and induces APC phosphorylation
in vivo. (A) Diagram showing the regions of human APC in-
cluded in three APC constructs. (B) Direct in vitro binding of
APC25 to Axin fragments containing the RGS domain. Sulfur-
35–labeled APC25 protein was incubated with S-tagged fusion
proteins containing the indicated regions of Axin. After S-pro-
tein agarose IP, bound APC25 was detected by SDS-PAGE and
autoradiography. Coomassie blue staining of the Axin fusion
proteins is shown at the bottom. (C) In vitro binding with NH2-
terminal Axin fragments reveals a second APC-binding site up-
stream of the RGS domain. Binding of APC2 and APC25 re-
quired the RGS domain (Ax96-353 and Ax96-480). However, FL
hAPC also interacted with Ax96-253, and hAPC2 bound Ax96-
253 very strongly. Interaction of Sulfur-35–labeled FL APC,
APC2, APC21 and APC25 with S-tagged fusion proteins was de-
termined as in B. (D) CoIP of VSV–APC with FL Axin and sev-
eral mutant forms of Axin. 293 cells were cotransfected with
VSV-G–tagged Xenopus APC (VSV–APC) and the indicated
Axin constructs. The cell lysates were immunoprecipitated with
anti-Myc and probed with anti–VSV-G antibody. Failure to de-
tect interaction with Ax12-355 was due to the very low levels of
VSV–APC observed when coexpressed with this particular con-
struct (E). (E and F) Axin-dependent phosphorylation of APC.
(E) Axin-induced mobility shift of VSV–APC. Total lysates from
cotransfected cells were analyzed by Western blot using an anti-
VSV mAb. FL Axin and mutants Ax12-810, 12-600, and 12-531
induced a mobility shift, whereas AxD251-351, Ax12-355, and
Ax497-622 did not. (F) Phosphatase treatment eliminated the
mobility shift. Cotransfected cell lysates were IP with anti-VSV
mAb, and the products were analyzed by SDS-PAGE and West-
ern blot before (left) or after (right) incubation with l-protein
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tion of the COOH terminus to remove the DIX domain,
or both the DIX and PP2A domains, caused only a slight
reduction, if any, in the ability to ventralize. Surprisingly,
there was no further reduction in activity when the region
including the b-catenin binding site was truncated (Ax12-
531) or removed by an internal deletion (AxD531-810).
Unlike the mutants with NH2-termini truncated at aa 194,
no dominant negative effect (dorsalization) was seen when
high concentrations were injected (Table II). Further trun-
cation, removing the GSK3b site, eliminated all activity
(Ax12-355). Internal deletion of only the RGS domain, in
the context of COOH-terminal truncations (mutant Ax12-
810D251-351, Ax12-672D251-351, and Ax12-531D251-351),
also eliminated ventralizing activity and instead cause
weak dorsalizing activity.
Dorsalization
In contrast to the ability of Axin and other inhibitors of
Wnt signaling (e.g., GSK3b) to ventralize when injected
dorsally, factors that stimulate this pathway (e.g., certain
Wnts, Dsh, dnGSK3b, or b-catenin) have dorsalizing ac-
tivity; when injected dorsally, they can hyperdorsalize (i.e.,
they induce formation of a larger head, large or multiple
cement glands, shorter axis, and double anterior axis).
However, their activity is best seen in ventral injections,
where they can induce a secondary axis (Miller and Moon,
1996; Fagotto et al., 1997; Fagotto, 1999). We previously
showed that a mutant Axin lacking the RGS domain
(AxD251-351) behaved as such a dorsalizing factor. This
activity could be competed by coexpression of FL Axin,
supporting the conclusion that it was due to a dominant
negative effect (Zeng et al., 1997). To identify the domains
of Axin required for this activity, several additional mu-
tant forms of Axin were also injected into the ventral side
of the embryo to assay their ability to induce axis duplica-
tion.
Sequences upstream from the RGS domain were not re-
quired, as an NH2-terminal truncation at aa 331 (Ax331-
956) induced axis duplication as efficiently as the RGS de-
letion (Figs. 3 and 4 F, Table II). However, the GSK3b
binding site was required as truncation at aa 531 abolished
the effect (Ax531-956). The COOH-terminal sequences
were also important: in the presence of the RGS deletion,
COOH-terminal truncation at aa 810, 672, or 530 strongly
reduced the dorsalizing activity so that axis duplication
Figure 3. Summary of properties of FL and
mutant forms of Myc-tagged Axin. The dia-
gram at the top indicates homology domains
and binding sites for other proteins based on
data reported here and previously (see text
for references). Numbers at left indicate the
NH2- and COOH-termini, and any internal
deletion (D). Dotted lines indicate deletions.
Vent., extent of ventralization (111 or 11)
or dorsalization (D, strong or d, weaker, and
only at high concentration) upon injection
into Xenopus embryos. b-cat level indicates
the effect on the level of expression of coin-
jected HA-tagged b-catenin: up arrow,
increase; side arrow, no change; and down
arrow, decrease. coIP indicates coimmuno-
precipitation with the indicated protein
(VSV–APC, endogenous GSK3b, or endoge-
nous  b-catenin) after transient transfection
into 293 cells. 1/2 indicates that coIP was
weak and sporadic in multiple assays. The
question mark indicates that the coIP of APC
could not be determined because expression
of these two Axin mutants greatly reduced
the total level of cellular APC (E and data
not shown). Localiz. indicates a pattern of in-
tracellular localization after injection into Xe-
nopus embryos. Sp and sp, strong or weak lo-
calization to spots, respectively; M and m,
strong or weak plasma membrane staining,
respectively; df, diffuse cytoplasmic staining;
asterisk, pattern was slightly particulate, in
contrast to other mutants labeled df. A blank
space indicates not determined.Fagotto et al. Structure-Function Analysis of Axin 747
was observed only when high concentrations of RNA were
injected. When the amount of injected RNA was titrated
down to yield expression levels at which AxD251-351
showed optimal activity, only Ax331-956 was active (Ta-
ble II).
Effects of Axin and Axin Mutants on b-Catenin levels
Modulation of the Wnt pathway has a striking effect on
b-catenin levels; in the absence of a Wnt signal, constitu-
tively active GSK3b phosphorylates b-catenin and causes
its rapid turnover, whereas Wnt signaling induces stabili-
zation of b-catenin. Therefore, we tested the effect of
Axin on b-catenin levels in Xenopus embryos by coex-
pressing HA-tagged b-catenin with FL or mutant forms of
Axin, or with b-galactosidase as a control. Low amounts of
HA-tagged b-catenin mRNA were used to mimic the be-
havior of endogenous b-catenin. At the late blastula stage,
when endogenous b-catenin signaling peaks (Lemaire et al.,
1995; Schneider et al., 1996), the levels of HA-tagged
b-catenin in embryo extracts were analyzed. The mem-
brane (cadherin-bound) pool of b-catenin is known to be
very stable (Kofron et al., 1997) and changes in b-catenin
levels by the Wnt signaling pathway affect mostly the un-
bound, soluble pool (Riggleman et al., 1990; Peifer et al.,
1994; Pai et al., 1997). Removing the cadherin-bound pool
of b-catenin by Con A precipitation made it possible to
obtain samples enriched in soluble b-catenin, allowing the
effect of Axin on b-catenin levels to be analyzed more ac-
curately. As shown in Fig. 5 B, FL Axin caused a dramatic
decrease in exogenous b-catenin. Several mutant Axin
constructs were coexpressed similarly; mutants with ven-
tralizing activity (Ax12-531 and Ax194-672) also proved to
be effective in reducing b-catenin levels. A mutant lacking
ventralizing activity (Ax531-956) had no effect on b-cate-
nin levels. On the other hand, mutants with strong domi-
nant negative activity (AxD251-351 and Ax331-956), in-
duced a clear increase in b-catenin levels. Unexpectedly,
mutant Ax194-531, which failed to ventralize over a wide
range of concentrations, but instead showed some dorsal-
izing activity, caused a strong decrease in b-catenin levels.
The activity of the dominant negative mutant AxD251-
351 was also tested on the ventral side, where the b-cate-
nin degradation machinery is maximally active. Under
these conditions, stabilization of b-catenin by AxD251-
351 could be observed even in total extracts (Fig. 5 C).
NH2 terminally deleted b-catenin (hemagglutinin epitope–
tagged D-NH2 terminus b-catenin; Funayama et al., 1995),
which lacks the GSK3b-dependent phosphorylation site
(Munemitsu et al., 1996; Yost et al., 1996), was found to be
insensitive to Axin overexpression (Fig. 5 D), suggesting
that Axin-induced destabilization of b-catenin requires
phosphorylation by GSK3b.
Intracellular Distribution of Axin
As the subcellular localization of endogenous Axin is so
far unknown, we examined the distribution of the ectopi-
cally expressed Myc-tagged Axin in Xenopus embryos. As
shown in Fig. 6, FL Myc–Axin exhibited a striking and un-
usual pattern. The signal was mostly concentrated in very
bright spots, which were found singly or in clusters of vari-
able size, mainly, but not exclusively, at the cell periphery
Figure 4. Ventralization and dorsalization by expression of Axin
mutants in Xenopus embryos. (A) Diagram of Axin molecule.
The main binding domains are indicated as well as the aa num-
bers corresponding to most restriction sites used in the genera-
tion of mutant Axin constructs. (B) Examples of ventralized em-
bryos (tailbud stage) obtained by dorsal injection of Ax194-672
mRNA. Two embryos have greatly reduced axes (arrowheads)
and no head. The other four embryos are completely ventralized
(i.e., they lack dorsal structures and have no body axis). (C) Em-
bryos expressing Ax531-956 develop normally. (D) Examples
of hyperdorsalized embryos obtained by dorsal expression of
Ax331-956. These embryos have enlarged heads and cement glands (large arrows) or double cement glands (small arrows). (E) Partially
dorsalized embryos resulting from dorsal expression of Ax194-531. These embryos typically form very large semicircular cement glands
(arrows) and their heads are generally strongly disorganized (arrowheads). (F) Axis duplication by ventral expression of Ax331-956.
Most of the embryos form complete twin embryos, including two cement glands (arrows). (G) Expression levels of FL and mutant Axin
constructs in embryos. (Left) An example of a series of constructs expressed dorsally. (Right) Expression levels of a series of constructs
with internal deletion of the RGS domain, expressed ventrally. Note that 1–2 ng Ax12-956D251-351 mRNA induced complete dupli-
cated axes (see Table II), whereas the other constructs expressed at similar or even higher levels induced mostly partial or no secondary
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(Fig. 6, A and A9, arrows). The rest of the cytoplasm was
devoid completely of the signal. In addition, some plasma
membrane staining was also observed. However, the
membrane staining was quite variable: absent in many
cells, weak in others (Fig. 6, A and A99, arrowhead), and
very strong in a few rare cells (not shown). The punctate
pattern and the absence of diffuse cytoplasmic staining
were observed at all mRNA concentrations used from 0.15
ng, the limit of detection by IF, to 2 ng. A similar pattern
was observed in Axin-transfected cultured HeLa (Fig. 6, B
and B9) and A6 cells (not shown).
Myc–Axin localization in Xenopus embryos was further
studied at the EM level by two different techniques: on-
section staining of Lowycryl sections (Fig. 7, A–C) and
preembedding labeling using Nanogold and silver en-
hancement (Fig. 7, D–F). Notwithstanding differences in
ultrastructure preservation and labeling sensitivity (see
legends), both methods gave similar results. Consistent
with IF data, Myc–Axin was found to be concentrated
highly in discrete areas of the cell. These areas were char-
acterized by clusters of vesicles (asterisks) surrounded by
gold-decorated electron dense material (arrows). Labeled
clusters varied largely in size and density, apparently as a
function of expression levels. Part of a loose cluster is
shown in Fig. 7 C. Small groups of gold particles associated
with a few vesicles and electron dense material could be
resolved, probably corresponding to the individual spots
detected by IF (Figs. 6 A9 and 7 A, arrows). On the other
hand, Fig. 7, D and E, shows very large dense Myc-positive
areas, where vesicles were tightly packed and conse-
quently the dense cytoplasm appeared less prominent. Fig.
7 B shows a cluster of intermediate size and vesicle den-
sity. Plasma membrane localization of FL Axin could not
be detected unambiguously by EM, probably because it
was generally too weak (Fig. 6 A, IF). However, strong
plasma membrane staining could be observed for the mu-
tant Axin AxD531-810 that is consistent with IF results
(Fig. 3).
Consistent with the IF data, Axin was found to be
largely particulate/sedimentable in differential centrifuga-
tion experiments (Fig. 8 B). On the other hand, it was
completely solubilized in the presence of a mild nonionic
detergent, NP-40 (Fig. 8 C). Thus, the sedimentation prop-
erties of Axin are not due to interaction with detergent-
insoluble cytoskeletal elements. In the presence of NP-40,
Axin could be partially precipitated using Con A beads
(Fig. 8 C), indicating that a pool of Axin is associated with
a membrane glycoprotein. We believe that this Axin–
membrane association involves the plasma membrane
pool of Axin, but not that in the intracellular spots, be-
Table I. Effect of Axin Mutants on Axis Development: Dorsal Injections
Mutant
Amount mRNA
injected
Total injected
embryos
Percent
ventralized§
Average
DAIi Ventralization
No.
exp¶
ng‡
FL (12-956) 2 3 0.13 28 46 3.6 1/2 2
FL (12-956) 2 3 0.25 57 70 2.5 1 2
FL (12-956) 2 3 2 103 94 1.0 111 6
D251-351 2 3 1–2 60 4 ? dorsalized 5
D352-631 2 3 1 61 26 4.3 2 4
D531-810 2 3 0.5–2 63 89 1.6 11 5
194-956 2 3 0.5–1 107 91 1.6 11 5
331-956 2 3 0.25 40 10 4.9 2 3
331-956 2 3 0.5–1 63 0 ? dorsalized 3
531-956 2 3 0.5–1.5 107 11 4.6 2 6
810-956 2 3 0.5–1 50 4 4.8 2 4
194-810 2 3 0.5–1 98 84 2.1 11 (*) 5
194-672 2 3 0.125–0.5 168 94 0.6 111 (*) 7
194-531 2 3 0.125–1 204 12 ? dorsalized 10
194-353 2 3 1–2 47 11 4.6 2 3
12-810 2 3 0.5–2 104 86 1.8 11 5
12-672 2 3 1 63 87 1.6 11 3
12-531 2 3 0.5–2 149 85 1.9 11 7
12-355 2 3 0.5–1 105 11 4.6 2 6
12-167 2 3 0.5–2 63 16 4.5 2 4
531-810 2 3 0.75–2 42 12 4.4 2 3
12-810D251-351 2 3 1 34 0 ? dorsalized 3
12-762D251-351 2 3 1–2 54 2 4.8 2 3
12-531D251-351 2 3 0.25–1 27 0 5.0 2 2
497-672 2 3 0.5–1 78 9 4.8 2 (d) 4
403-600 2 3 0.25–1 119 8 4.9 2 (d) 7
‡Because expression levels varied considerably between different constructs, mutant Axin mRNAs were systematically titrated and expression levels were compared by Western
blot, using the levels obtained with 2 3 2 ng FL Axin mRNA as a reference.
§Percent ventralization indicates the frequency of embryos with a DAI ,4.
iDAI, dorso anterior index; DAI 0, completely ventralized; DAI 5, normal; and DAI 10, completely dorsalized.
(?), Dorsalized embryos obtained by dorsal injections cannot be scored accurately for DAI, because DAI values .5 are based on a somewhat different phenotype (LiCl-treated
embryos). (d), some dorsalized embryos. (*), dorsalized phenotype at high concentrations.
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cause binding to Con A of all Axin deletion mutants tested
(Fig. 8 D) strictly correlated with plasma membrane local-
ization (as detected by IF, see below).
Colocalization of Dsh with Axin
The punctate distribution of Axin strongly was reminis-
cent of the localization pattern of ectopically expressed
Dsh (Yang-Snyder et al., 1996; Axelrod et al., 1998) (the
distribution of endogenous Dsh in Xenopus is not known).
Thus, we compared the localization of coexpressed Myc-
tagged Axin and HA–Dsh by double IF. We observed a
very good colocalization of these two proteins (Fig. 6, C
and C9): HA–Dsh was detected at all sites positive for
Myc–Axin (arrowheads), although some other spots were
positive for Dsh but negative for Axin (arrows). The Myc–
Axin pattern in these embryos was indistinguishable from
the pattern observed in the absence of exogenous Dsh,
suggesting that Dsh does not influence Axin localization.
In contrast, Myc–Axin overexpression clearly affected
HA–Dsh distribution: when HA–Dsh was expressed alone,
it localized exclusively in single cytoplasmic spots, or small
clusters of spots, distributed throughout the cell (Fig. 6 D).
No membrane staining was observed. However, when co-
expressed HA–Dsh and Myc–Axin colocalized in a pat-
tern typical for overexpressed Axin (enrichment of spots
at the cell periphery, presence of large clusters, and
plasma membrane staining). These results suggest that
Dsh may bind, directly or indirectly, to the Axin complex.
Sequences Required for Axin Localization
To examine the sequences in Axin that target it to its spe-
cific locations, and the functional significance of this local-
ization, we examined the intracellular distribution of the
same mutant forms used above. Internal deletion of the
RGS domain had little or no effect on localization; the mu-
tant protein localizing primarily in the spots and less at the
plasma membrane (Fig. 3 and Fig. 9, B and C). Deletion of
the GSK3b and b-catenin binding sites (AxD352-631) also
had no effect on localization to the spots, but eliminated
the membrane staining (Fig. 9, H and I). Deletion of the
COOH-terminal 146-aa resulted in localization mainly at
the membrane, with little or no labeling of the spots, e.g.,
Ax12-810 (not shown) Ax12-672 (Fig. 9 F), Ax12-531 (Fig.
9 G), and Ax12-355 (Fig. 9 J).
Forms of Axin lacking the NH2-terminal half displayed
a mostly diffuse cytoplasmic localization, e.g., Ax497-672
(Fig. 9 D). When the APC and GSK3b-binding domains
were left intact, there seemed to be some enrichment at
the cell periphery (Fig. 9 E, Ax194-956), although it was
difficult to assess the extent of membrane enrichment, be-
cause of the high cytoplasmic signal.
Thus, the NH2 terminus of Axin appears to be required
for the characteristic pattern of localization, both in the cy-
toplasmic spots and at the membrane. The presence of
the normal COOH terminus tends to cause localization to
the spots, although it is not absolutely required for this.
The COOH terminus, which includes a dimerization do-
main, might bind to endogenous Axin or to other cellular
components. The APC and GSK3b binding sites appear to
have a weaker effect on localization at the membrane. The
membrane localization of mutants containing the NH2 ter-
minus correlates very well with Con A binding (Fig. 8 C).
For instance, Ax12-531 binds very efficiently to Con A,
whereas Ax531-956 does not bind at all. However, local-
ization to the spots appears to depend on a different mech-
anism, only a small fraction of FL Axin and an even
smaller fraction of AxD351-630 (found mostly in spots)
bind to Con A (Fig. 8 C and data not shown).
Table II. Effect of Axin Mutants on Axis Development: Ventral Injections
Mutant
Amount mRNA
injected
Total injected
embryos Percent DA Dorsalization cDA pDA vDA N
No.
exp
ng
FL (12-956) 1–4 58 0 2 00 05 8 4
D251-351 1–2* 148 80 111 54 65 12 17 9
D352-631 1 39 0 2 00 03 9 3
331-956 0.25 59 19 1 0 11 0 48 3
331-956 1* 129 87 111 83 29 3 14 4
531-956 0.5–1.5 62 0 2 00 06 2 3
194-531 0.5 97 24 1 91 4 3 6 3 84
194-353 0.5–1 34 0 2 00 43 0 2
12-672 1 49 0 2 00 04 9 2
531-810 0.75–1 34 0 2 00 03 4 2
12-810D251-351 0.25* 23 0 2 00 22 1 2
12-810D251-351 0.5–2‡ 149 56 11 15 69 6 59 9
12-762D251-351 0.25–2 168 1 2 0 1 10 157 9
12-531D251-351 0.25* 28 0 2 00 02 8 2
12-531D251-351 0.5–2‡ 53 30 1 4 12 6 31 4
497-672 0.5 45 0 2 00 04 5 2
403-600 0.5–1 91 3 2 03 08 8 4
*Expression levels equivalent to 1–2 ng FL Axin mRNA.
‡Expression levels higher than for FL and 12-956D251-351 Axin.
DA, duplicated axis; percent DA, all duplicated axis (cDA 1 pDA)/total injected embryos; cDA, complete DA; pDA, partial DA; vDA, vestigial DA; N, normal embryos; and No.
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Discussion
Axin has been shown to negatively regulate signaling
through components of the Wnt pathway. Coinjection ex-
periments in Xenopus embryos previously suggested that
it acts downstream of GSK3b and upstream of b-catenin.
Subsequent studies have shown that Axin is part of a com-
plex including these two proteins as well as APC and that
it promotes the phosphorylation of b-catenin by GSK3b
and its subsequent degradation (Hart et al., 1998; Ikeda et
al., 1998; Itoh et al., 1998; Kishida et al., 1998; Sakanaka et
al., 1998). The aims of the experiments reported here were
to understand the relationship between Axin’s ability to
bind to these and other proteins and its capacity to func-
tion in the regulation of this pathway. To this end, we have
examined a series of Axin mutants for their ability to (1)
bind to APC, GSK3b, and b-catenin; (2) ventralize or dor-
salize Xenopus embryos, an established assay for effects
on b-catenin signaling; and (3) alter the stability of b-cate-
nin expressed from coinjected mRNA. In addition, we
have examined the intracellular localization of FL Axin
and a series of Axin mutants.
Interaction of Axin with Other Components of the Wnt 
Signaling Pathway
Through direct binding in vitro and coIP from mammalian
cell extracts, we have confirmed that Axin forms a com-
plex with APC, GSK3b, and b-catenin, and we have fur-
ther delimited some of the binding sites for these proteins.
Based on coIP, the region of mAxin required for inter-
action with GSK3b lies between aa 497 and 531. The
COOH-terminal boundary of the minimal binding region
appears to lie between aa 526 and 531. Whereas Itoh et al.
(1998) did not detect coIP of GSK3b with Axin 12-526, we
detected weak interaction of GSK3b with some Axin mu-
tants terminating at aa 531. We confirmed that the RGS
domain (aa 220–340) includes a major binding site for
APC and interacts with the 20-aa repeat region of APC.
Furthermore, we identified a second region of Axin, be-
tween aa 96–253, that can bind directly to the NH2-termi-
nal region of APC containing the Armadillo and 15-aa re-
peats. This region of Axin was neither necessary nor
sufficient for coIP with VSV-G–tagged APC, suggesting
that it plays a secondary role to the RGS domain in vivo.
We observed good agreement between the presence of
the direct binding site for GSK3b (Ikeda et al., 1998) and
the ability of Axin mutants to coIP with GSK3b (Fig. 4).
Axin mutants lacking this region, some of which were able
to coIP with APC and/or b-catenin, all failed to coIP with
GSK3b, suggesting that GSK3b must bind directly to Axin
to join the complex. However, several forms of Axin that
lacked the direct binding site for either APC or b-catenin
were able to coIP with both of these proteins. APC was
found to coIP not only with all forms of Axin containing
the RGS domain, but also with Ax331-956, which lacks
any direct binding site for APC. Similarly, b-catenin could
coIP not only with all Axin mutants containing aa 600–622,
but also with Ax12-531 and Ax194-531. Both of these dis-
crepancies likely are due to the ability of APC and b-cate-
nin to bind to each other (Rubinfeld et al., 1993; Su et al.,
1993). Since each of these three components can interact
directly with the other two, we suggest that they form in
vivo a triangular complex (Fig. 10).
The GSK3b binding domain was dispensable for direct
binding to APC and b-catenin, but required for indirect
binding to b-catenin (presumably via APC). Indeed, a
small fragment of Axin containing only the RGS domain
(Ax194-353), while able to coIP with APC, did not coIP
Figure 5. Expression of Axin and Axin mutants affects b-catenin
stability. (A) Diagram of Axin molecule. (B) Dorsal injection of
FL Axin and several mutant constructs downregulate free b-cate-
nin levels. HA-tagged b-catenin mRNA (75 pg) was coinjected
with b-galactosidase mRNA (control), or the indicated Myc-
tagged forms of Axin, in the dorsal side of early cleaving em-
bryos. mRNA amounts (see Materials and Methods) were
selected to produce equivalent levels of expression of Axin
constructs, and b-galactosidase mRNA was added to equalize
amounts of injected mRNA. Extracts from late blastula embryos
were depleted of cadherin-bound b-catenin using Con A beads
and the levels of free HA–b-catenin were analyzed by immuno-
blot. Duplicate samples correspond to two independent pools of
seven embryos each. FL and several mutant forms (Ax12-531,
Ax194-531, and Ax194-672) strongly reduced b-catenin levels.
On the other hand, AxD251-351 and Ax331-956 caused an in-
crease in b-catenin levels. Ax531-956 had no effect. (C) Stabiliza-
tion of total b-catenin by ventral injection of AxD231-351.
HA–b-catenin mRNA was coinjected with b-galactosidase,
AxD251-351, FL Axin, or HA-dnGSK3b mRNAs in the ventral
side of cleaving embryos. Total levels of HA–b-catenin were
compared directly by immunoblot. AxD251-351, but not FL
Axin, induced an increase in b-catenin comparable to the in-
crease obtained with dnGSK3b (Yost et al., 1996). The lower
panels show expression of HA-dnGSK and of the Myc-tagged
Axin constructs. (D) Axin downregulates FL b-catenin, but not
NH2-terminally truncated b-catenin. HA-tagged b-catenin or
DNb-catenin mRNA (750 pg) were coinjected dorsally with
b-galactosidase mRNA (control, 2 ng) or FL Axin mRNA (2 ng).
Total levels of HA–b-catenin were compared.Fagotto et al. Structure-Function Analysis of Axin 751
Figure 6. Myc-tagged Axin localizes in discrete
spots and colocalizes with HA–Dsh. (A) Cellular
distribution of FL Myc–Axin (green, Alexa488
staining) in Xenopus blastulae, detected by indirect
IF on frozen sections. Myc–Axin localized mainly in
spots (small arrows) or clusters of spots (large ar-
rows), found generally but not exclusively at the cell
periphery. Some plasma membrane staining was
also observed (arrowhead). Red shows yolk plate-
lets counterstained with Eriochrome Black; blue
shows the nuclei (DAPI staining). (A9) Large clus-
ter of Myc–Axin-positive spots (arrows) at higher
magnification. (A99) Detail of membrane localiza-
tion of Myc–Axin (arrowheads). Spots also are
found at or near the cell surface (arrow). (B and B9)
Localization of FL Myc–Axin in transfected HeLa
cells. Myc–Axin (red, Cy3 staining) is found in spots,
mostly at the cell periphery. In high expressing cells,
bright cytoplasmic clusters were observed (B9, ar-
rows). (B99) Detail of two clusters at high magnifica-
tion (arrows). Note that images in A and A99 and B
and B99 were collected under very different condi-
tions (exposure, filters), since the signal was one or-
der of magnitude stronger in transfected HeLa cells
compared with mRNA-injected embryos. Blue
shows the nuclei (DAPI staining). (C and C9) Colo-
calization of FL Myc–Axin and HA–Dsh. Coex-
pressed Myc–Axin (green, Alexa488 staining) and
HA–Dsh (red, Cy3 staining) were detected on sec-
tions from Xenopus blastulae by double IF. All
Myc–Axin colocalized perfectly with HA–Dsh (ar-
rowheads), but some HA–Dsh spots did not stain
for Myc–Axin (arrows). Note that most Axin-Dsh
spots are distributed along the periphery of the cells.
(D) Localization of HA–Dsh expressed alone: Dsh
(red, Cy3 staining) localizes in spots, distributed
throughout the cytoplasm. Blue shows nuclei
(DAPI). Bars: (A) 10 mm; (A9) 2 mm; (A99) 5 mm; (B
and B9) 10 mm; (B99) 5 mm; (C and D) 20 mm.
with b-catenin. Conversely, Ax531-956 was found to coIP
with b-catenin but not with APC. We also found that Axin
induced a mobility shift in APC that appeared to be due to
phosphorylation. This activity required the GSK3b-bind-
ing domain as well as the APC-binding region, suggesting
that GSK3b is responsible for this modification. It previ-
ously has been shown that GSK3b can phosphorylate
APC in vitro (Rubinfeld et al., 1996), that Axin promotes
this event (Hart et al., 1998), and that this phosphorylation
enhances the ability of APC to bind to b-catenin (Rubin-
feld et al., 1996). Our observations argue that Axin per-
forms a similar function in vivo.
Axin Sequences Required to Influence Axis Formation 
and Regulate b-Catenin Levels in Frog Embryos
In general, we found a good correlation between the abil-
ity of Axin mutants to ventralize frog embryos and to
lower the levels of coinjected HA-tagged b-catenin, pre-
sumably by promoting its degradation. The RGS domain
and GSK3b binding site were both required, although not
sufficient, for Axin activity. In addition, either the b-cate-
nin binding site or the NH2-terminal region upstream of
the RGS domain (but not necessarily both) was required.
The activity of mutant forms of Axin lacking the b-catenin
binding site (e.g., Ax12-531 and AxD531-810) is consistent
with the observation that such forms can coIP with b-cate-
nin in 293 cells, apparently via an indirect interaction. Why
the NH2-terminal sequence can substitute for the b-cate-
nin binding site is not clear, but this could be related to its
ability to bind to APC or its influence on the intracellular
localization of Axin.
Fragments of Axin containing the GSK3b and b-catenin
binding sites, but lacking the RGS domain, can promote
the phosphorylation of b-catenin by GSK3b in vitro
(Ikeda et al., 1998) as well as the degradation of endoge-
nous b-catenin in cultured SW480 cells (Hart et al., 1998).
However, in our experiments, all forms of Axin lacking
the RGS domain either had no effect on axis formation
and b-catenin levels or they dorsalized rather than ventral-
ized the frog embryo and raised b-catenin levels. This indi-
cates that direct binding to APC plays a critical role in the
ability of Axin to promote the degradation of b-catenin.
These discrepancies may be due to the peculiar proper-
ties of SW480 cells that lack FL APC and have high levels
of soluble b-catenin. In contrast, we used very low levels
of exogenous b-catenin that can still be effectively regu-
lated by the Wnt pathway (Yost et al., 1996). In other ex-The Journal of Cell Biology, Volume 145, 1999 752
periments (Fig. 5 C), we found that FL Axin was able
to downregulate even very large amounts of coinjected
b-catenin. However, under these conditions several Axin
mutants gave results that were inconsistent with their ef-
fects at more physiological b-catenin levels and with their
activity on axis induction. In particular, both dominant
negative mutants AxD251-351 and Ax331-956 failed to sta-
bilize b-catenin expressed at high levels, but rather caused
some destabilization (not shown). Thus, Axin is capable of
stimulating  b-catenin degradation independently of the
RGS domain, but only provided high levels of free b-cate-
nin and/or absence of APC. Consistent with this observa-
tion, the Axin-like protein Conductin/Axil/Axin-2 appears
to behave similarly. Indeed, a DRGS Conductin construct
could downregulate b-catenin levels in SW480 cells, yet
acted as a dominant negative (i.e., increased b-catenin lev-
els) in Neuro2A cells, which have low levels of endoge-
nous b-catenin and FL APC (Behrens et al., 1998). It is
likely that high levels of b-catenin are flooding the system,
bypassing normal regulatory mechanisms. Nevertheless, it
is also possible that two different mechanisms exist, one
APC-dependent, and one APC-independent, active at low
and at high b-catenin concentrations, respectively (see be-
low).
Surprisingly, in SW480 cells, truncation of the NH2 ter-
minus, including the RGS domain, increased the activity
of Axin that led to the proposal that the RGS domain may
repress Axin activity in the absence of APC (Hart et al.,
1998). However, this mutant construct could not discrimi-
nate between a role of the RGS domain itself and an effect
of upstream sequences. In contrast, DRGS Conductin, a
mutant with an internally deleted RGS domain and an in-
tact NH2 terminus, showed weaker activity than FL Con-
ductin in SW480 cells, arguing that the RGS domain is not
responsible for the apparent repression reported by Hart
et al. (1998). In fact, SW480 cells are not null for APC, but
still contain an NH2-terminal fragment, which can bind
b-catenin (Polakis, 1995), and can also interact with the
NH2 terminus of Axin upstream of the RGS domain (our
data). Thus, it is conceivable that the truncated APC may
interfere with Axin activity.
In embryos, deletion of the RGS domain caused a
strong dominant negative effect. The self-binding region
(including the DIX domain) appeared to play a role in this
activity, because deletion of this region from AxD251-351
substantially reduced activity. As the COOH-terminal 100
aa of Axin can mediate multimerization, the strong domi-
nant negative forms of Axin may act by binding to endoge-
Figure 7. Electron microscopic localization of Myc–
Axin. (A–C) EM localization of FL Myc–Axin by
on-section staining on Lowycryl sections. (A) Low
magnification view of an Axin-positive cluster de-
tected by indirect IF on a thin section. Axin expres-
sion in this cell is relatively low and individual spots
can be resolved (arrows). (B) Low magnification
EM image of a cluster of gold particles (15 nm) la-
beling an area of dense cytoplasm (arrows) contain-
ing numerous vesicles (asterisks). Note that outside
the cluster the surrounding cytoplasm is devoid of
gold particles. (C) High magnification view of por-
tion of a less dense cluster. The cluster is composed
of small groups of gold particles decorating electron
dense cytoplasm (arrows) associated with a few vesi-
cles (asterisks). Each small group probably corre-
sponds to a single “spot” observed by IF (A and
Fig. 6, A and B). Note that the membranes sur-
rounding the vesicular structures appear much less
contrasted in B and C compared with E. This is due
to the difference in the methods used (low contrast
Lowycryl sections in B and high contrast conven-
tional Spurr sections in D). (D and E) EM localiza-
tion of Myc–Axin by preembedding Nanogold label-
ing and silver enhancement. (D) Low magnification
view of a Myc–Axin positive area (arrow) in a high
expressing cell. Single gold aggregates found both in
the cytoplasm and in the nucleus (n) represent back-
ground that is higher with this preembedding tech-
nique. The arrowhead points to the plasma mem-
brane that shows no significant staining in this cell. (E) High magnification view of a similar area, packed with vesicles of variable size
(z50-200 nm) embedded in electron dense cytoplasm. The irregular shape of the gold/silver particles is due to the silver enhancement
method. Insert shows enlarged view (23) of the outlined area, with tightly-packed vesicles (asterisks) and electron dense cytoplasm (ar-
row). Note that gold labeling tends to be somewhat excluded from the areas particularly packed with vesicles. This could be due to lim-
ited diffusion of Nanogold in these preparations. (F) Nanogold localization of Myc–Axin at the plasma membrane. Because FL Axin lo-
calization at the membrane is weak (D, and Fig. 7 A), a mutant Axin, AxD531-810 was used in this experiment. In this case, the plasma
membrane is heavily decorated with gold/silver particles (arrowheads). m, mitochondrion; p, pigment granules; and yp, yolk platelets.
Bars: (A) 2 mm; (B) 1 mm; (C) 0.2 mm; (D) 1 mm; (E) 0.5 mm; (F) 1 mm.Fagotto et al. Structure-Function Analysis of Axin 753
nous Axin. However, forms of Axin lacking the DIX do-
main also showed weak or moderate dorsalizing activity
(Ax12-810D251-351 and Ax12-531D251-351), suggesting
that dominant negative activity may be generated in more
than one way. One possibility is that these forms of Axin
bind to GSK3b but not to APC, thus, interfering with the
formation of the complete complex. Also, two mutants
lacking both the NH2 and COOH termini (Ax194-672 and
Ax194-810) efficiently ventralized at low concentrations,
but dorsalized at high concentrations. This dual activity
might be related to their subcellular localization (see be-
low).
The NH2- and COOH-terminal portions of Axin were
not required for its ventralizing activity in our assays, as
also observed by Itoh et al. (1998), although they may
modulate its function. Deletion of the DIX domain had lit-
tle or no effect on activity. Deletion of the PP2A binding
region caused some increase in activity of the forms of
Axin that initiated at aa 194, although this difference was
not apparent when the NH2 terminus of Axin was left in-
tact. We have hypothesized that the binding of PP2A to
the Axin complex might counteract the phosphorylation
of b-catenin by GSK3b (Hsu et al., 1999) that could ac-
count for the increased ventralization activity in the ab-
sence of this domain.
The Intracellular Localization of FL and Mutant Forms 
of Axin
FL Myc–Axin expressed in Xenopus embryos was found
primarily in characteristic spots, singly or in clusters of
variable size. Ultrastructural analyses indicated that the
spotty distribution is not merely due to aggregation of
an overexpressed protein, but corresponds to particular
(though as yet ill-defined) subcellular structures, consist-
ing of clustered vesicles associated with dense cytoplasm.
Several arguments suggest that endogenous Axin has a
similar distribution including: (1) identical spots were ob-
served over a wide range of Axin expression levels. (2)
HA–Dsh (Fig. 6) accumulated in similar spots in the ab-
sence of overexpressed Axin. (3) Myc–Axin colocalized
with HA–Dsh (Fig. 6). However, the formation of large
clusters of spots very likely is due to Axin overexpression,
as it was not observed for HA–Dsh in the absence of Axin
expression. However, it may reveal the ability of Axin to
act as a scaffold through multiple interactions with other
cytoplasmic proteins. A small, variable fraction of Myc–
Axin was also associated with the plasma membrane, and
Con A-binding showed that Axin interacts with a cell sur-
face glycoprotein. The NH2 terminus is sufficient for mem-
brane targeting, although some other internal sequences
may also confer weaker binding. Interestingly, the se-
quences of Axin crucial for its subcellular localization (i.e.,
the NH2 and COOH termini) do not bind any of the core
components related to its activity (APC, b-catenin, and
GSK3b), and are apparently dispensable, at least under
conditions of overexpression (Fig. 10). Clearly, additional
molecular interactions must take place at both ends of the
molecules.
The occurrence of two well-defined locations for Myc–
Axin may reflect the existence of two functionally distinct
pools, possibly an active and an inactive one. Ectopically
expressed Dsh shows a similar dual localization at spots/
membrane, which can be manipulated by overexpression
of Wnt/Frizzled, and that may correspond to different
functional states (Yanagawa et al., 1995; Axelrod et al.,
1996; Steitz et al., 1996; Yang-Snyder et al., 1996). How-
ever, which would be the active and inactive sites remains
unclear. The comparison of various Axin mutants did not
reveal any simple correlation between their activity in
functional assays and their intracellular distribution, al-
though all active mutants can to some extent localize at
the plasma membrane. However, it is quite possible that
localization per se is not required for activity, but that reg-
ulation is achieved by sequestering various components of
the signaling pathway in different compartments of the
cell. It is then easy to conceive that overexpression may
bypass such regulation and allow Axin/Axin mutants to in-
Figure 8. Cell fractionation of Myc–Axin in Xenopus embryos: sedimentability and Con A binding. (A) Diagram of Axin molecule. (B)
Myc–Axin is associated with a sedimentable fraction. Homogenates of late blastula embryos were fractionated into a low speed sedi-
mentable fraction (P, pellet), a high speed sedimentable fraction (M, membranes), and a high speed supernatant (S, soluble fraction) as
described in Materials and Methods. b-Galactosidase was coexpressed and used as a control for soluble cytosolic proteins. Unlike
b-galactosidase, Myc–Axin was sedimentable under these conditions. (C) Myc–Axin is fully extractable in NP-40. Embryos expressing
Myc–Axin were extracted in NP-40–containing buffer (sol). The insoluble pellet was reextracted in the presence of SDS (insol, NP-40–
insoluble). (D) A pool of Axin is associated with a membrane glycoprotein, and this association requires the NH2-terminal domain.
Myc-tagged FL Axin and various Axin mutant constructs were expressed in embryos, and NP-40 extracts were fractionated using Con
A beads. Bound fractions (B) were four times concentrated relative to unbound fractions (U). FL Axin showed significant association
with Con A beads that indicates a stable interaction with a membrane glycoprotein. Stronger binding was observed for the NH2-termi-
nal fragments Ax12-531. On the other hand, constructs lacking the NH2-terminal domain showed no (Ax-531-956 and Ax194-353) or
very weak binding (Ax194-956).The Journal of Cell Biology, Volume 145, 1999 754
Figure 9. Sequence specific patterns of cellular dis-
tribution of Axin mutants. FL and various mutant
forms of Myc-tagged Axin were expressed in Xeno-
pus embryos and localized by IF (green) on frozen
sections. Diagram of Axin molecule. (B and C) FL
and AxD251-351 localized preferentially to spots or
clusters of spots (arrows). Variable membrane stain-
ing was detected in some cells (B and insert C, ar-
rowheads). This pattern was found for all constructs
containing both NH2- and COOH-termini. (D) Dif-
fuse cytoplasmic distribution of Ax497-672 found in
most constructs lacking the NH2 terminus. (E) Ex-
ample of a mutant (Ax194-956) showing a cytoplas-
mic, but somewhat particulate, distribution with
some weak enrichment at the cell periphery (arrow-
head). Partial cell surface enrichment is characteris-
tic of mutants lacking the NH2 terminus but with
intact APC and GSK3b-binding sites. (F and G)
Constructs containing the NH2 terminus but lacking
the COOH terminus, such as Ax12-672 and Ax12-
531, are mainly localized at the plasma membrane
(arrowheads). Some intracellular punctate staining
is also observed (arrows). (H) Localization of
AxD352-631 mimics the punctate staining of FL
Axin (arrows). (I and J) High magnification views of
punctate staining (I, AxD352-631) and membrane
staining (J, Ax12-355). Bars: (A–G) 20 mm; (H, I,
and insert B) 5 mm.
teract with other components of the complex indepen-
dently of upstream signals.
Our observations provide some hints for a role of Axin
localization. For instance, the concentration-dependent
dual activity of Ax194-672 and Ax194-810 may be related
to their diffuse distribution; at high concentrations, they
could act as dominant-negatives by affecting the balance
between various endogenous components otherwise strictly
compartmentalized. This dual activity was also found for
the Axin-like protein Axil/Conductin/Axin-2 that has a
similar diffuse distribution (Zhang, T., F. Fagotto, and F.
Costantini, manuscript in preparation), but was never ob-
served with Axin constructs showing a well-defined local-
ization (spots and/or plasma membrane).
Conclusions and Models
Our functional data emphasize the essential role of the
RGS domain for Axin activity (Fig. 10). They demonstrate
that binding to GSK3b and to b-catenin, which was re-
ported to stimulate b-catenin phosphorylation in vitro
(Hart et al., 1998; Ikeda et al., 1998), is not sufficient in
vivo either for b-catenin degradation or for inhibition of
its signaling. Although the RGS domain may interact with
other yet uncharacterized molecules, its importance most
likely resides in its ability to bind APC, thus inducing the
formation of a trimeric complex Axin•b-catenin•APC
(Fig. 10). Note that the RGS domain of Axin is signifi-
cantly diverged from the sequences of bona fide RGS pro-
teins (Tesmer et al., 1997; Zeng et al., 1997), and does not
appear to bind to G-proteins (our unpublished data) or to
have RGS activity (Mao et al., 1998). Apparently, it has di-
verged toward other interactions and functions.
The apparent discrepancy with other data that suggests,
under certain conditions, Axin can function without the
RGS domain (Hart et al., 1998), may be best reconciled byFagotto et al. Structure-Function Analysis of Axin 755
postulating two mechanisms, active at different levels of
free b-catenin: When b-catenin levels are low, b-catenin
degradation would depend primarily of an Axin·b-cate-
nin·APC complex, whereas when b-catenin levels are
high,  b-catenin·Axin complexes may form and function in
the absence of APC. Both mechanisms may be physiologi-
cally important: in the absence of Wnt signal, very low lev-
els of free b-catenin might be maintained by the combined
action of Axin and APC. However, after a burst of Wnt
signal, excess b-catenin would be first downregulated by
an APC-independent coarse mechanism, before fine tun-
ing by APC could eventually restore normal levels.
The occurrence of an Axin-based complex has further
potential implications on the regulation of the pathway by
Wnt. It had been assumed that Wnt caused b-catenin sta-
bilization by inhibiting GSK3b activity (for review see
Miller and Moon, 1996). However, GSK3b inhibition
could hardly account for the specificity of the pathway,
considering the many other substrates and pleiotropic
functions of GSK3b. We now know that binding of
GSK3b to Axin is required for phosphorylation of Axin,
APC, and b-catenin, and ultimately for activity of the
complex (Hart et al., 1998; Ikeda et al., 1998; this paper;
Jho, E.-H., manuscript submitted for publication). There-
fore, inhibition of Axin-GSK3b binding, or in fact any
other interactions within the complex, could be a far more
specific way to regulate this pathway. This might be pre-
cisely the function of Dsh. In this context, the distinct cel-
lular pools of Axin may reflect the existence of different,
active and inactive, complexes. The challenge will be to
characterize the nature of these complexes and their regu-
lation by upstream components of the pathway.
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